Literature DB >> 18947331

Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.

Andrea Rachinger1, Marjon Navis, Sander van Assen, Paul H P Groeneveld, Hanneke Schuitemaker.   

Abstract

A human immunodeficiency virus type 1 (HIV-1)-infected elite controller (defined as an untreated HIV-1-infected person with a plasma HIV-1 RNA level <50 copies/mL for at least 12 months) who experienced a viremic episode after superinfection regained natural viremic control, although the viral loads in the patient's 2 partners, infected with the same viral strain, were continuously approximately 30-fold higher. Thus, host mechanisms seem to be able to repeatedly control HIV-1 replication, halting disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18947331     DOI: 10.1086/592978

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  Control of simian immunodeficiency virus SIVmnd-1 RNA plasma viremia after coinfection or superinfection with SIVmnd-1 in SIVmnd-2-infected mandrills and vice versa.

Authors:  Florian Liégeois; Delphine Verrier; Edward Greenwood; Fabian Schmidt; Jonathan Heeney; François Rouet
Journal:  J Virol       Date:  2012-02       Impact factor: 5.103

Review 2.  HIV-1 replicative fitness in elite controllers.

Authors:  Michael A Lobritz; Kara G Lassen; Eric J Arts
Journal:  Curr Opin HIV AIDS       Date:  2011-05       Impact factor: 4.283

3.  Vital role for CD8+ cells in controlling retroviral infections.

Authors:  Melissa Kane; Laure K Case; Tatyana V Golovkina
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

Review 4.  Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?

Authors:  Joel N Blankson
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

Review 5.  Frequency and implications of HIV superinfection.

Authors:  Andrew D Redd; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Infect Dis       Date:  2013-05-31       Impact factor: 25.071

6.  Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda.

Authors:  Deogratius Ssemwanga; Frederick Lyagoba; Nicaise Ndembi; Billy N Mayanja; Natasha Larke; Shuyi Wang; Joshua Baalwa; Carolyn Williamson; Heiner Grosskurth; Pontiano Kaleebu
Journal:  Virology       Date:  2011-01-15       Impact factor: 3.616

7.  Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller.

Authors:  María Pernas; Concepción Casado; Carolina Arcones; Anuska Llano; Víctor Sánchez-Merino; Beatriz Mothe; José L Vicario; Eulalia Grau; Lidia Ruiz; Jorge Sánchez; Amalio Telenti; Eloísa Yuste; Christian Brander; Cecilio López- Galíndez
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

8.  Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study.

Authors:  Nicolas Noel; Nathalie Lerolle; Camille Lécuroux; Cécile Goujard; Alain Venet; Asier Saez-Cirion; Veronique Avettand-Fenoël; Laurence Meyer; Faroudy Boufassa; Olivier Lambotte
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  Sustained Viremic Control in HIV-Infected Patient: Case Report from Nepal.

Authors:  Sundar Khadka; Subhash Dhital; Roshan Pandit; Anup Bastola
Journal:  Case Rep Infect Dis       Date:  2018-03-13

10.  HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity.

Authors:  Maria Pernas; Victor Sanchez-Merino; Concepcion Casado; Alberto Merino-Mansilla; Isabel Olivares; Eloisa Yuste; Cecilio Lopez-Galindez
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.